August 2, 2018 / 12:36 PM / 4 months ago

BRIEF-Novartis Pharma Canada Says Health Canada Approved Aimovig

Aug 2 (Reuters) - Novartis AG:

* NOVARTIS PHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVED AIMOVIG FOR PREVENTION OF MIGRAINE IN ADULTS WHO HAVE AT LEAST 4 MIGRAINE DAYS PER MONTH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below